Speech-Language Pathologists in Delaware - Medicare Status, Address, Contact

571 Speech-Language Pathologists found. Showing 61 - 80

Melissa Caitlin Seither Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 278 Sorghum Mill Rd, Camden, DE 19934 Phone: 302-697-3103

Heather Anne Pirino, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 278 Sorghum Mill Rd, Camden Wyoming, DE 19934 Phone: 302-697-3103

Carissa Stevens, SP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 278 Sorghum Mill Rd, Camden Wyoming, DE 19934 Phone: 302-697-3103    Fax: 302-697-4998

Karen Thomas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937

Susan Kushmeider, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994

Roberta L Oneill Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937

Patricia Bailey Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Maple Ln, Claymont, DE 19703 Phone: 302-792-3994

Joan Lochrie Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994

Jenine Goren Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937

Aline M Holler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937

Therese Taha Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Maple Ln, Claymont, DE 19703 Phone: 302-792-3994

Mrs. Mary Kate Koziol Rhoades, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-8585

Christine Fenimore Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-8587

Claire Kunkel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-8587

Amanda Goodwin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-2803

Amanda Campbell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-2803

Shannon Hardee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Clayton Elementary, 510 Main Street, Clayton, DE 19938 Phone: 302-653-2803

Megan Thomas, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 Main St, Clayton, DE 19938 Phone: 302-653-2803

Donna C. Bartrug Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N 8th St, Delmar, DE 19940 Phone: 302-846-9544

Jennifer Crouse, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 S Governors Ave, Dover, DE 19904 Phone: 302-744-7095

News Archive

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received grants totaling nearly $35 million in 2009.

Biota increases damages claim against GlaxoSmithKline

Australian company Biota has filed its updated Particulars of Loss and Damage in its suit against GlaxoSmithKline (GSK) for failing to support the influenza drug, Relenza, discovered by Biota and licensed to GSK in 1990.

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

"Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and published Wednesday in the New England Journal of Medicine (NEJM), the San Francisco Chronicle reports.

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »